340B drug discount program entities; remove distributor from prohibition of certain discriminating actions related to.

This bill removes pharmaceutical distributors from a state law that prohibits certain discriminatory actions against entities participating in the federal 340B drug discount program. It clarifies that only drug manufacturers (not distributors) are barred from interfering with 340B drug access or delivery to contracted pharmacies. The law directly affects hospitals, clinics, and other 340B program participants by changing which entities face restrictions on their interactions with drug distributors. The bill died in committee in February 2025 and did not advance to become law.